PH14796A - Method of treating arthritic disease - Google Patents

Method of treating arthritic disease

Info

Publication number
PH14796A
PH14796A PH22358A PH22358A PH14796A PH 14796 A PH14796 A PH 14796A PH 22358 A PH22358 A PH 22358A PH 22358 A PH22358 A PH 22358A PH 14796 A PH14796 A PH 14796A
Authority
PH
Philippines
Prior art keywords
arthritic disease
treating arthritic
treating
disease
arthritic
Prior art date
Application number
PH22358A
Other languages
English (en)
Inventor
Andrew Stephen Tomcufcik
Adolph Edward Sloboda
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PH14796A publication Critical patent/PH14796A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/48Two nitrogen atoms
    • C07D251/50Two nitrogen atoms with a halogen atom attached to the third ring carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/42One nitrogen atom
    • C07D251/44One nitrogen atom with halogen atoms attached to the two other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/54Three nitrogen atoms
    • C07D251/70Other substituted melamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH22358A 1978-04-12 1979-04-06 Method of treating arthritic disease PH14796A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89557278A 1978-04-12 1978-04-12

Publications (1)

Publication Number Publication Date
PH14796A true PH14796A (en) 1981-12-09

Family

ID=25404704

Family Applications (2)

Application Number Title Priority Date Filing Date
PH22358A PH14796A (en) 1978-04-12 1979-04-06 Method of treating arthritic disease
PH22357A PH16084A (en) 1978-04-12 1979-04-06 Novel anti-arthritic 2,4,6-tris-(substitutedamino)-s-triazine

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH22357A PH16084A (en) 1978-04-12 1979-04-06 Novel anti-arthritic 2,4,6-tris-(substitutedamino)-s-triazine

Country Status (16)

Country Link
EP (1) EP0005586B1 (xx)
JP (1) JPS54145686A (xx)
AT (1) AT368145B (xx)
AU (2) AU525420B2 (xx)
BE (1) BE875490A (xx)
CA (1) CA1122977A (xx)
CH (1) CH641170A5 (xx)
DE (2) DE2914051A1 (xx)
DK (1) DK153779A (xx)
ES (1) ES479566A1 (xx)
FI (1) FI66181C (xx)
IE (1) IE48128B1 (xx)
IL (1) IL56949A (xx)
PH (2) PH14796A (xx)
PL (1) PL214821A1 (xx)
ZA (2) ZA791262B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521560A1 (fr) * 1982-02-17 1983-08-19 Adir Nouveaux derives de piperazine et d'homopiperazine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
AT389303B (de) * 1987-10-08 1989-11-27 Hoechst Ag Neue bis-tertiaerbutylamino-substituierte 1,3,5-triazinderivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
US5658923A (en) * 1992-09-18 1997-08-19 Asahi Kasei Kogyo Kabushiki Kaisha Azepine derivatives and use thereof
EP0661271B1 (en) * 1992-09-18 2000-04-26 Asahi Kasei Kogyo Kabushiki Kaisha Azepine derivatives, production thereof, and use thereof as sigma-receptor ligands

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE680661C (de) * 1937-06-23 1939-09-06 I G Farbenindustrie Akt Ges Verfahren zur Herstellung von in den Aminogruppen substituierten cyclischen Amidinen
US3270014A (en) * 1965-07-01 1966-08-30 Upjohn Co 1, 2-dihydro-1-hydroxy-1, 3, 5-triazines
DE1620528A1 (de) * 1965-12-31 1970-06-11 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen basisch substituierten s-Triazinen
BR6915234D0 (pt) * 1969-05-22 1973-06-07 American Cyanamid Co Novos derivados de melamina e processo para sua preparaca
DE2027430A1 (de) * 1970-06-04 1971-12-16 Deutsche Gold und Silber Scheide anstalt vormals Roessler, 6000 Frank fürt Verfahren zur Herstellung von substituierten s Tnazinen
US3706741A (en) * 1971-08-11 1972-12-19 Christos George Papaioannou Process for preparing 2,4,6-tris(tert alkylamino)-s-triazines

Also Published As

Publication number Publication date
JPS54145686A (en) 1979-11-14
AU530512B2 (en) 1983-07-21
IE48128B1 (en) 1984-10-03
FI66181B (fi) 1984-05-31
AU525420B2 (en) 1982-11-04
IL56949A0 (en) 1979-05-31
DE2914052A1 (de) 1979-10-25
ATA270979A (de) 1982-01-15
AT368145B (de) 1982-09-10
ZA791299B (en) 1980-07-30
DK153779A (da) 1979-10-13
BE875490A (fr) 1979-10-11
PH16084A (en) 1983-06-20
DE2914051A1 (de) 1979-10-25
ZA791262B (en) 1980-07-30
IE790769L (en) 1979-10-12
ES479566A1 (es) 1979-12-01
FI791185A (fi) 1979-10-13
IL56949A (en) 1986-03-31
EP0005586A1 (en) 1979-11-28
JPH0138114B2 (xx) 1989-08-11
CA1122977A (en) 1982-05-04
DE2914052C2 (xx) 1990-04-26
AU4536579A (en) 1979-10-18
EP0005586B1 (en) 1982-04-28
CH641170A5 (de) 1984-02-15
AU4536679A (en) 1979-10-18
PL214821A1 (xx) 1980-07-01
FI66181C (fi) 1984-09-10

Similar Documents

Publication Publication Date Title
JPS54113442A (en) Treating agent of hyperlipoid disease
JPS5547870A (en) Medical treatment method
JPS5597272A (en) Method of forming organic thinnfilm
JPS5532595A (en) Method of sterilizing solid
PH15861A (en) Method of treating skin disease with keratinization
PH20118A (en) Method for the treatment of hyperlemia
GB1553424A (en) Method of treating protozal diseases
GB2013640B (en) Slag treatment process
JPS5777009A (en) Method of treating sulfur
ZA786811B (en) Method of treating hypertension
PH14796A (en) Method of treating arthritic disease
JPS549453A (en) Method of treating nighttsoil
JPS5558055A (en) Treating of euphausiacea
JPS5581967A (en) Joint treatment method
JPS5581657A (en) Purifying waterrremoving method of blood
JPS54111496A (en) Crosssbreeding method of shrimps
JPS5555760A (en) Method of treating joint
JPS5568972A (en) Method of treating joint
GB2037816B (en) Heat treatment method
DE2965550D1 (en) Method of treating mica
ZA786096B (en) Method of treating arthritic disease
JPS54109651A (en) Heat treatment method of waterrheat pipe
JPS55111545A (en) Method of treating joint
JPS55111544A (en) Method of treating joint
BG30328A3 (en) Method for obtaining of o, o- dimethyl- o, 2, 2- dichlorvinyl- phosphate